C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction

Area of Science:

• Genetics
• Cardiovascular Medicine
• Biochemistry

Background:

• High-sensitivity C-reactive protein (hs-CRP) is a key inflammatory marker associated with predicting acute myocardial infarction (AMI).
• Genetic factors influencing baseline CRP levels may contribute to cardiovascular disease risk.
• Understanding gene polymorphisms related to CRP is crucial for assessing heart disease predisposition.

Purpose of the Study:

• To investigate the association between the CRP 1059G/C gene polymorphism and plasma CRP levels.
• To determine if this polymorphism is linked to the risk of developing AMI in an Egyptian population.

Main Methods:

• Genotyping of 150 AMI patients and 150 healthy controls using PCR-restriction fragment length polymorphism.
• Quantification of hs-CRP concentrations in all participants.
• Statistical analysis to compare genotype frequencies and CRP levels between groups.

Main Results:

• No significant association was found between the CRP 1059G/C polymorphism and the occurrence of AMI.
• Individuals with the GG genotype exhibited significantly higher plasma CRP concentrations compared to those with GC and CC genotypes.
• This difference in CRP levels was observed in both the control group (3.82 ± 1.03 vs. 2.34 ± 0.7; P=0.001) and the AMI patient group (8.39 ± 2.6 vs. 6.67 ± 2.4; P=0.005).

Conclusions:

• The CRP 1059G/C gene variation demonstrably influences plasma CRP levels.
• However, this specific polymorphism is not associated with an increased risk of acute myocardial infarction.
• Further research may explore other genetic or environmental factors contributing to AMI risk.